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Abstract
Background: Three approaches exist to deal with the impact of comorbidity in burden of disease studies - the
maximum limit approach, the additive approach, and the multiplicative approach. The aim of this study was to
compare the three comorbidity approaches in patients with temporary injury consequences as well as comorbid
chronic conditions with nontrivial health impacts.
Methods: Disability weights were assessed using data from the EQ-5D instrument developed by the EuroQol
Group and derived from a postal survey among 2,295 injury patients at 2.5 and 9 months after being treated
at an emergency department. We compared the observed and predicted EQ-5D disability weights in
comorbid cases using data from injury patients with and without comorbidity who were restored from their
injuries at 9 months follow-up. The predicted disability weights were calculated using the maximum limit
approach, additive approach, and multiplicative approach. The intraclass correlation coefficient (ICC) was used
to test whether the values of the observed disability weights and the three model-predicted disability weights
were correlated.
Results: The EQ-5D disability weight of injury patients increased significantly with the number of comorbid
diseases. The ICCs of the additive, multiplicative, and maximum limit models were 0.817, 0.778, and 0.674,
respectively. Although the 95% confidence intervals of the ICCs of the three models overlap, the maximum
limit model seems to fit less well than the additive and multiplicative models. For mild to moderate chronic
disease (disability weight below 0.21), the association between predicted and observed disability weights was
low.
Conclusions: Comorbidity has a high impact on disability measured with EQ-5D. Ignoring the effect of
comorbidity restricts the use of the burden of disease concept in multimorbid populations. Gains from health care
or interventions may be easily overestimated if a substantial number of patients suffer from additional conditions.
The results of this study found that in accounting for comorbidity effects, all three models showed a strong
association between the predicted and observed morbid disability weight, though the maximum limit model
seems to fit less well than the additive and multiplicative models. The three models do not fit well in the case of
mild to moderate pre-existing disease.
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Burden of disease studies quantify the health status of a
population in order to facilitate the work of policy-
makers in setting priorities in health care and preven-
tion [1,2]. Commonly, the outcome of such studies is
expressed in disability-adjusted life years (DALYs), a
summary measure of population health. Apart from the
obvious advantages of a uniform summary measure of
population health, the calculation and interpretation of
the burden of disease in terms of DALYs can be compli-
cated if multiple conditions co-exist in individuals. The
fact that multiple conditions co-exist in individuals may
be a matter of chance related to general susceptibility (e.
g., advanced age) or the consequence of a disease with
multiple systemic manifestations and remote complica-
tions. Nevertheless, assignment of the observed burden
to separate conditions, either in descriptive terms or in
terms of the total computed burden of disease, is arbi-
trary, and several difficulties emerge.
The first difficulty is that the straightforward additive
use of DALYs per disease is limited as this assumes that
the total burden of two or more diseases is the sum of
the burden of diseases taken separately. A second diffi-
culty occurs in so-called counterfactual impact analysis
of risk factors. What happens in terms of population
DALYs if one disease is eradicated? The answer depends
on a valid solution of the comorbidity assignment
problem.
Furthermore, the comparative outcomes research faces
problems to the extent that outcome differences can vir-
tually disappear through the overriding effects of comor-
bid conditions. The common practice to exclude
patients with comorbidity from participation in trials
postpones rather than solves the question concerning
the average population effect of an intervention.
Comorbidity is defined as the presence of any clinical
condition that qualifies for formal classification as a dis-
ease additional to the disease under study. Risk factors
such as advanced age, ethnic background, or obesity are
essentially not comorbid conditions, although the princi-
ples described below also might be applicable.
At present, three approaches exist to deal with the
impact of comorbidity with regard to burden of disease
studies [3,4]. These approaches are elaborated here.
The first approach is the maximum limit approach.
This approach counts the disease with the highest over-
all disability weight. The approach assumes that a
comorbid disease does not affect disability of a patient
with a primary disease, unless the comorbid disease, in
general terms, exceeds the disability of the former.
The second approach is the additive approach. This
approach assumes that the additional effect, or more
precisely, the utility loss, of comorbid disease simply
adds to the effect (utility loss) of the primary disease
observed in uniconditional patients. The disability
weights of the comorbid diseases are added up.
The third approach is the multiplicative approach.
This method assumes that a comorbid disease increases
the utility loss of a patient, though it is less than the
sum of the utility loss of both diseases independently.
Here, we present a systematic comparison of the three
comorbidity adjustment approaches in patients with
injuries and common diseases with non-trivial health
impacts as the secondary condition.
Methods
Design
We compared the observed (gold standard) and pre-
dicted disability weights in comorbid cases, using data
from the EQ-5D instrument developed by the EuroQol
Group for injury patients with and without comorbidity.
For this comparison, long-term follow-up data from
injury patients could be used because the onset of injury
is acute, causing immediate, yet usually temporary func-
tional loss. This allows the measurement of utility loss
due to comorbid injury and disease (comorbid utility
loss) and the measurement of utility loss due to the
injury and disease separately (uniconditional utility loss).
The comorbid utility loss was used to calculate the
observed disability weights in comorbid cases. The uni-
conditional utility loss was used to calculate the pre-
dicted disability weights with the maximum limit,
additive, and multiplicative approaches. See Figure 1 for
a schematic model of the design.
Patient data
The primary data sources were existing national registry
data on injured patients upon hospital admission,
enhanced with functional outcome data obtained from
patients by surveys at regular intervals.
Registry data
T h er e g i s t r yd a t aw e r ed e r i v e df r o mt h eD u t c hI n j u r y
Surveillance system, a permanent registry of injuries
treated at the emergency departments (ED) of a repre-
sentative sample of 17 hospitals (about 10%-15% of ED
capacity) in the Netherlands. The registry collects infor-
mation on age and sex of the patient, cause and type of
the injury, body region affected, and treatment of the
sustained injury [5].
Follow-up survey
The follow-up survey was administered between 8 Octo-
ber 2001 and 31 December 2002 to a sample of 8,564
patients aged 15 years and older who were treated at
t h eE Da n dw h o s er e g i s t r yd a t aw e r ea v a i l a b l et h r o u g h
the Dutch Injury Surveillance System [5]. The patients
were treated at the ED followed by either hospital
admission or direct discharge to the home environment.
The sample of patients consisted of victims of traffic,
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The sustained injuries varied from minor to severe inju-
ries and hospitalized and nonhospitalized patients. The
sample of patients was stratified, oversampling hospita-
lized patients. Each injury patient of the selected sample
received a postal questionnaire 21/2 months after the
injury, and 3,167 (37%) responded. The first question-
naire was anonymous for privacy reasons. At 5, 9, and
24 months following the injury, a follow-up question-
naire was sent to patients who responded to the preced-
ing questionnaire. For these questionnaires, the patients
needed to give permission by an informed consent form.
The present study used a sample of 2,295 respondents
(i.e., 27% of the original sample) who responded to the
21/2-month and 9-month post-trauma survey.
Utility measurement and disability weight
To measure utility after injury, the questionnaire included
the multi-utility attribute instrument EQ-5D. With the
EQ-5D classification system, subjects describe their health
state by assigning themselves to one of three function
levels (grades) in five separate domains: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression
[6,7]. Subsequently, the utility weight of that health state
was computed by a formula that first yields a partial
weight score for each domain depending on the reported
level, and then adds the utility weights (also referred to as
the tariff) derived at an earlier stage from preference data
of the United Kingdom population [8].
For the subsequent calculation of the EQ-5D disability
weights, we used the population health index of the
population of the United Kingdom, adjusted for age and
sex [9]. To calculate the EQ-5D disability weight, the
measured EQ-5D utility weight was subtracted from the
UK population norm for a person of that age and sex
(see additional file 1). For instance, 21/2 months after
sustaining a fracture of the lower extremity, a male
patient aged 30 reported some problems with walking
and performing usual activities, as well as moderate pain
or discomfort (EQ-5D profile 21221), resulting in a uti-
lity weight of 0.69. The UK population norm for a male
aged between 25 and 35 is 0.93. The EQ-5D disability
weight was subsequently calculated by subtracting 0.69
from 0.93, resulting in an EQ-5D disability weight of
0.24. Patients with a disability weight of ≤ 0w e r e
excluded from the analysis.
Observed disability weight in comorbid cases
The survey included a question that asked whether
patients were restored from their injuries (yes/no). This
study was restricted to injury patients who indicated
that they were restored from their injury after nine
months of follow-up. Furthermore, the questionnaire
included 19 items regarding the presence of one or
more chronic diseases prior to the injury to assess
comorbidity [10]. Comorbidity is defined as the presence
of any co-existing medical diseases or disease processes
additional to the injury that the injury patients sustained
Healthy Healthy Injury
Cases without pre-existing disease
Disease Disease Disease +
injury
        Time
Injury 2.5 months 9 months Recovery
injury
Cases with pre-existing disease
                 = comorbid utility loss
                 = uni-conditional utility loss
Figure 1 Design of the study.
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symptoms that were most often reported - chronic,
non-specific lung disease; heart disease; diabetes; back-
ache; osteoarthritis; and rheumatoid arthritis.
The comorbid injury and disease disability weight was
obtained from the 21/2 month EQ-5D data reported by
injury patients with comorbid disease.
Predicted disability weight in comorbid cases
To predict the disability weight in comorbid cases with
the maximum limit, additive, and multiplicative
approaches, uniconditional disability weights were used.
The uniconditional disability weight of the injury was
obtained from the 21/2-month EQ-5D data reported by
injury patients without comorbid disease. The effects of
the injury consequences on utility can be measured at
21/2 months after sustaining the injury, given that the
selected patients were restored at 9 months post-injury.
This assumption allows measurement of the disability
effects of the comorbid disease only. Therefore, the uni-
conditional disability weights of the disease were
obtained from the 9-month EQ-5D data of injury
patients with comorbid disease.
These uniconditional disability weights were then
used to calculate the predicted disability weight in
cases of injury and comorbid disease according to the
three approaches. In the examples supporting the for-
mulas used to calculate the comorbid disability
weights, the injury type “leg fracture” serves as the pri-
mary disease, and heart disease is an example of pre-
existing disease.
Predicted disability weights: maximum limit approach
To calculate comorbid disability weight with the maxi-
mum limit approach, we used the following formula:
dwcombined =d w leg fracture + hear disease =m a x ( d w heart disease,dw leg fracture).
The maximum limit approach is biased if two condi-
tions affect different health domains of the EQ-5D
(underestimation by model-based cancellation).
Predicted disability weights: additive approach
To calculate comorbid disability weight with the additive
approach, we used the following formula:
dwleg fracture + heart disease =d w leg fracture +d w heart disease.
One limitation is that the combined disability may
exceed 1.0. Bias may arise if both diseases affect the
same health domain of the EQ-5D; for example, the
effect of diabetic foot amputation does not add to a
lower leg fracture of the same leg (overestimation by
data cancellation).
Predicted disability weights: multiplicative approach
To calculate comorbid disability weight with the multi-
plicative approach, we used the following formula:
dwleg fracture + heart disease =1− (1 − dwleg fracture) ∗ (dwheart disease).
Analysis
For the analysis of the data, the Statistical Package for
the Social Sciences (SPSS) version 16.0 was used (SPSS
I n c . ,C h i c a g o ,I L ) .O n e - w a yA N O V Aw a su s e dt ot e s t
for differences in disability weights among patients with
and without comorbid disease. The intraclass correlation
coefficient (ICC) was used to determine the goodness-
of-fit of the predicted comorbid disability weights using
the three comorbidity adjustment methods. In this way,
we tested whether the values of the observed disability
weights and the three model-predicted disability weights
were correlated.
To test whether the relations between observed and
predicted disability weights depended on the severity of
the comorbid disease, the pre-existing disease was
grouped into two severity classes using the median
value of the 9-month disability weight of patients with
comorbid disease (0.21) as a cut-off (range 0.0-0.21 is
the less severe group).
Results
Of the 2,295 injury patients who completed the follow-
up surveys 21/2 and 9 months after they were treated at
the ED, 1,438 (62.7%) indicated they were restored from
their injury at 9 months follow-up.
The 21/2-month EQ-5D disability weights increased
significantly with the number of comorbid diseases (F =
31.8, p < 0.001). For instance, injury patients with a con-
cussion and no comorbid disease had a mean EQ-5D
Table 1 Mean uniconditional disability weights of the
injury groups, obtained from EQ-5D data from injury
patients without comorbid disease at 21/2 months
follow-up
Injury type N Mean
1 CI
2
Skull - brain injury 192 .06 .04-.08
Facial fracture, eye injury 51 .05 .02-.07
Spine, vertebrae 26 .18 .10-.27
Internal organ injury 61 .05 .03-.07
Upper extremity fracture 188 .07 .05-.09
Upper extremity, other injury 64 .09 .05-.12
Hip fracture 12 .21 .11-.32
Lower extremity fracture 151 .15 .13-.18
Lower extremity, other injury 74 .13 .10-.16
Superficial injury, open wounds 158 .06 .04-.07
Burns 14 .05 <.01-.12
Poisonings 16 .06 <.01-.12
Other injury 51 .06 .04-.09
1Adjusted for age and sex of the patient
2 CI = confidence interval
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two or more comorbid diseases had mean EQ-5D dis-
ability weights of 0.08 and 0.35, respectively. Table 1
shows the uniconditional disability weights of the injury
groups that were obtained from 21/2-month EQ-5D
data of injury patients without comorbidity.
Table 2 presents the mean uniconditional EQ-5D dis-
ability weights of the diseases. Heart disease had the
lowest mean EQ-5D disability weight of 0.07. Osteoar-
thritis had the highest mean disability weight (0.38).
The mean observed and predicted comorbid disability
weights, where the predicted disability weights were cal-
culated with the three different adjustment approaches,
are shown in Table 3.
Figure 2 shows the relationship between the observed
and predicted disability weights for the injury types and
comorbid diseases. The predicted disability weights were
calculated for each injury patient separately. In Figure 2,
each data point represents a patient.
The ICC between the observed and predicted comorbid
disability weights was highest for the additive approach
(ICC = 0.817; 95% confidence interval [CI]: 0.681-0.898).
The ICCs of the multiplicative approach and maximum
limit approach were 0.778 (95% CI: 0.463-0.812) and
0.674 (95% CI: 0.619-0.876), respectively.
As shown in Table 4, in cases of severe chronic dis-
ease, all three models showed a strong association of the
predicted and observed comorbid disability weight. For
mild to moderate chronic disease (disability weight
below 0.21), the association between predicted and
observed disability weights was low, especially for the
maximum limit model.
Discussion
The results of this study show that the EQ-5D disability
weight of injury patients increases with the number of
comorbid diseases. The goodness-of-fit of the three
models to account for comorbidity effects was found to
be high. Although the 95% confidence intervals of the
ICCs of the three models overlap, the maximum limit
model seems to fit less well than the additive and multi-
plicative models.
Analysis of the goodness-of-fit of the three models
stratified by severity of the pre-existing disease indicated
that the three models do not fit well in cases of mild to
moderate pre-existing disease.
Very few studies have used actual patient data to ver-
ify the validity of comorbidity adjustment approaches.
Flanagan et al. tested the multiplicative approach using
empirical utility data from the Canadian Community
Health Survey [12]. They showed that observed and pre-
dicted utility was highly associated. However, it should
be noted that Flanagan et al. tested only the multiplica-
tive approach and that they measured health loss using
the Health Utilities Index (HUI), whereas in the current
study, the EQ-5D was used. Both are generic instru-
ments. The functional health state of the patient and
the utility weights derived from the population are
based on generic attributes and without regard to the
underlying disease, disease-specific key symptoms, prog-
nosis, or treatment. Evidence suggests that the sensitiv-
ity of the EQ-5D is low compared to the HUI, implying
that the EQ-5D does not measure disability where the
HUI does [13]. Additionally, Polinder et al. showed that
among injury patients, the HUI is more sensitive for
Table 2 Mean uniconditional disability weights of pre-
existing diseases, obtained from EQ-5D data of injury
patients at 9 months follow-up
Pre-existing disease n Mean
1 CI
2
CNLD
3 7 .12 .05-.19
Heart disease 11 .07 .07-.15
Diabetes 6 .21 .01-.51
Backache 8 .26 .01-.69
Osteoarthritis 30 .38 .20-.56
Rheumatoid arthritis 10 .16 .01-.41
Other disease 51 .23 .11-.19
1 Adjusted for age and sex of the patient
2 CI = confidence interval
3 CNLD = Chronic nonspecific lung disease
Table 3 Mean observed and predicted comorbid disability weights
1 (pre-existing diseases and injury)
Predicted
Observed Max limit approach Additive approach Multiplicative approach
CNLD
2 and injury 0.23 (0.04) 0.18 (0.02) 0.30 (0.06) 0.28 (0.05)
Heart disease and injury 0.28 (0.26) 0.17 (0.01) 0.26 (0.08) 0.24 (0.07)
Diabetes and injury 0.33 (0.17) 0.18 (0.02) 0.30 (0.01) 0.28 (0.01)
Backache and injury 0.19 (0.19) 0.12 (0.02) 0.14 (0.02) 0.14 (0.02)
Osteoarthritis and injury 0.52 (0.35) 0.39 (0.29) 0.49 (0.34) 0.44 (0.28)
Rheumatoid arthritis and injury 0.25 (0.19) 0.18 (0.04) 0.25 (0.08) 0.23 (0.07)
Other disease and injury 0.30 (0.22) 0.22 (0.13) 0.30 (0.17) 0.28 (0.14)
1 Mean disability weight (standard deviation)
2 CNLD = Chronic nonspecific lung disease
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might be caused by the crudeness of the levels, three in
the case of the EQ-5D compared to five or six levels of
the HUI. Comparison of the visual analogue scale (VAS)
scores of patients with and without comorbid disease
might clarify this issue. The VAS valuation technique
requires patients to score their health state on a vertical
thermometer graded from 0 (worst possible health state)
to 100 (best possible health state). Unfortunately, it was
not possible to assess the effects of comorbid disease
and injury with the VAS because too many VAS scores
were missing.
An important limitation that applies to the current study
and the study of Flanagan et al.[12] is that utility scores
were used to test the comorbidity adjustment approaches
rather than the impact on the separate health domains of
the multi-attribute utility instruments. This limitation may
be overcome by a fourth adjustment approach that starts
from the domain- specific impact of a disease without
comorbidity and compares this impact to the estimated
domain impact of the comorbidity only. By selecting the
maximum impact for each domain, a maximum limit pro-
file is derived with the worst of both diseases for each
domain. Subsequently, the total utility and disability weight
Maximum limit approach
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Figure 2 Observed and predicted disability weights for comorbid conditions.
Table 4 Goodness-of-fit of observed comorbid disability weights and comorbid disability weights predicted with the
three adjustment approaches, stratified by severity of the disease
Severity Maximum limit approach ICC
(95% CI)
Additive approach ICC (95%
CI)
Multiplicative approach ICC
(95% CI)
Mild to moderate chronic disease (dw <
0.21)
.073 (-.269 - .401) .399 (.073 - .649) .351 (0.17 - .615)
Severe chronic disease (dw ≥ 0.21) .887 (.530 - .979) .953 (.780 - .992) .933 (.699 - .988)
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approach can accommodate co-existing diseases that share
affected domains or the presence of two or more comorbid
diseases. It does, however, require detailed descriptive data.
A second limitation that may have affected the results
of the current study is that health loss of co-existing dis-
ease and temporary consequences of injury were mea-
sured using patient-reported EQ-5D data. As a result,
adaptation might have affected the patient-reported EQ-
5D data. The selected co-existing diseases were chronic,
and adaptation to their chronic health state might have
caused patients to value their health state as less severe.
This effect is especially found regarding chronically ill
patients [15,16]. The level of adaptation possibly differs
between patients with mild to moderate and severe
chronic disease and this may explain the differences
found in association between predicted and observed
disability weights in cases of severe chronic disease com-
pared to mild to moderate chronic disease.
Of the injury patients restored from their injuries 9
months after injury, 12% reported comorbid disease.
This percentage was lower compared to the total sample
of injury patients, of which 29% of the patients reported
comorbid conditions. This latter percentage is compar-
able to the proportion of patients with comorbid disease
found in previous studies [17,18].
A third limitation of the current study is that pre-injury
utility scores of the injury patients were unavailable. There-
fore, 9-month disability weights were used to calculate the
comorbid disease with the three comorbidity adjustment
approaches. We assumed that the 9-month disability
weights of patients who were restored from their injury cap-
ture the health loss due to chronic, pre-existing disease
without the effects of the injury and that the health loss
caused by the pre-existing comorbid disease at 9 months
was similar to the health loss at 21/2 months post-injury.
However, the severity of the disease might have changed
over time. Regarding rheumatioid arthritis, for instance,
symptoms may vary over time. This may have resulted in
either under- or overestimation of the health loss due to
the pre-existing disease at 21/2 months post-injury.
Furthermore, the comorbidity adjustment approaches
were tested with EQ-5D data. The use of the EQ-5D to
assess the impact of injury and comorbidity has its limita-
tions. One of these limitations is that the EQ-5D has
large ceiling effects in the general population [19]. These
ceiling effects may also affect the measurement of health-
related quality of life measured by EQ-5D among injury
patients with mild short-term injury. However, in this
study, in order to use empirical data to test the comor-
bidity adjustment approaches, actual reported patient
data were required. Therefore, we have used disability
weights based on EQ-5D data. Evidence suggests that
EQ-5D utility scores of individuals may be influenced by
medical as well as nonmedical factors, such as age and
sex, educational level, and marital status [9,20]. In the
current study, the disability weights were adjusted for age
and sex. Other nonmedical factors that may have affected
the reported EQ-5D health states reported by the injury
patients were not taken into account.
Conclusions
By assuming a single-disease hypothesis, the standard
application of the DALY metric fails to consider the fact
that more than one disease may exist simultaneously in a
patient [21]. Apart from the difficulty of distinguishing
primary and secondary diagnosis, ignoring comorbid dis-
ease in burden of disease estimates restricts the use of
the DALY in multimorbid populations, such as the
elderly in high-income countries. Gains from care may
easily be overestimated if a substantial number of
patients suffer from additional diseases. In cases where
disorders are more often held to be secondary than pri-
mary, their significance in burden of disease studies and
the benefit of eradication may be underestimated. This
has implications for priority setting and prevention and
may lead to wrongful policy recommendations.
The results of this study showed that the goodness-of-
fit of available comorbidity adjustment approaches was
high. The maximum limit model, however, seems to fit
less well than the additive and multiplicative models.
Furthermore, analysis of the goodness-of-fit of the three
models stratified by severity of the pre-existing disease
indicated that the three models do not fit well in cases
of mild to moderate pre-existing disease.
To improve current approaches to adjust for comor-
bidity, we recommend more research on the effects of
comorbidity on health-related quality of life. In this
study, the effects of temporary injuries and chronic dis-
ease have been investigated. It remains to be investi-
gated whether the effect of multiple chronic diseases on
health-related quality of life and the performance of the
available adjustment approach are similar.
In addition, other adjustment approaches should be
developed. The currently available methods rely upon
the disability weight, yet other methods, such as a
domain-specific method, should be explored.
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